News by subject: HEALTH

Novan, Inc. ("the Company" or "Novan") and EPI Health, a Novan Company, today announced that eight abstracts have been accepted for poster presentation at the 42nd Annual Fall Clinical Dermatology Conference® being held October 20-23, 2022, in Las...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") a clinical stage Canadian pharmaceutical development company, is pleased to announce that Dr. Rick Strassman, author of the book DMT: The Spirit Molecule and Algernon consultant, will be...

Marble is using their flagship legal product, Medchart, to provide claimant authorization to law firms representing patients in the Mallinckrodt Pharmaceuticals opioid lawsuit. Powered by Marble's APIs, Medchart enables mass tort and personal injury...

National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies : This year, the company has trained a large and growing community of physical therapists to use its innovative...

October 13, 2022 International University of Health and Welfare, Mita Hospital, Tokyo, employs Philips' augmented reality (AR) surgical navigation solution to treat first patients in Japan, helping to bring the patient benefits of...

BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on December 15, 2022, to shareholders of record at...

In a detailed open letter, signed onto by the Decent Work and Health Network and released by Health for All Network, nearly a thousand health workers across Canada are prescribing permanent resident status for all to save lives. The letter comes a...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ("Coherus") today announced the publication of toripalimab plus chemotherapy for patients with treatment-naïve advanced non-small cell...

October 12, 2022 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today provided an update on its third-quarter 2022 financial results and full-year outlook. The company will report the final results on October 24,...

RTOERO is sounding the alarm on issues of dignity and survival during British Columbia municipal election campaign. This month, it launched a digital campaign urging British Columbians to speak with one voice on three critical issues: environmental...

RTOERO is sounding the alarm on issues of dignity and survival during Ontario municipal election campaign. This month, it launched a digital campaign urging Ontarians to speak with one voice on three critical issues: environmental stewardship,...

LifeLabs recently hosted the grand opening of its newest Patient Service Centre in Kanata. Dr. Merrilee Fullerton, MPP for Kanata?Carleton, joined LifeLabs to celebrate this milestone in bringing care closer to home and expanding access to...

October 11, 2022 Philips receives Center for Health Design ?Touchstone Award' for exemplary use of evidence-based design in Ambient Experience solutions that help the emergency department at Children's Medical Center Dallas improve care for...

Cannabix Technologies Inc. (the "Company or Cannabix") developer of marijuana breathalyzer devices for law enforcement and the workplace reports it will be participating in a mid-October study date to test a supplemental version of its FAIMS...

ChristianaCare, a leading non-profit health system in the mid-Atlantic region, today announced it has spun out its first commercial biotechnology private start-up company, named CorriXR Therapeutics. CorriXR Therapeutics (pronounced Cor-ix-er; from...

Incannex Healthcare Limited (?Incannex' or the ?Company'), a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, is pleased to announce...

The Lachine Hospital Foundation and the MUHC Foundation are launching the Dream Big: Lachine Hospital campaign to raise $5M to purchase state-of-the-art equipment for the expanded Lachine Hospital. With a $210M investment from the Quebec government,...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is joining the World Health Organization's (WHO) 2022 World Mental Health Day campaign to...

Reunion Neuroscience Inc. ("Reunion" or the "Company"), a leader in novel psychedelic drug development committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds, today...

Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable Carolyn Bennett, has publicly stated that safe drug...

Peel Regional Police Service (PRP) and TELUS have announced the signing of a Memorandum of Understanding (MOU) to advance 5G innovation and deploy technologies that will keep our communities safe. This association will support mission critical...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company's U.S. Food & Drug...

In Canada, the vast majority of COVID-19 cases in the 0 to 18 age group have been mild or asymptomatic. This fact, combined with the reduction in routine COVID-19 laboratory testing across most of the country, means that the infection rates in...

URAC joins leaders to announce the Mental Health at Work Index, the first-of-its-kind comprehensive strategy to measure, improve and innovate workplace mental health.  URAC is a partner in the Founding Corporate Council to support the development...

Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced an update on its actively enrolling...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the pricing of an underwritten public offering of: (i)...

Kane Biotech Inc. (the "Company" or "Kane Biotech") today announces that it has received an additional $425,000 USD of funding for its DispersinB Hydrogel® related to its Medical Technology Enterprise Consortium Research Project Award which was...

MCI Onehealth Technologies Inc. ("MCI") , a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and Khure Health, an MCI wholly-owned subsidiary that provides artificial intelligence-based patient...

Blue-Zone Technologies, Ltd. (Blue-Zone), www.blue-zone.com, the world's first Clean-Tech Pharmaceutical company focused on the sustainable capture and recovery of waste anesthetic gasses, resulting in the production of branded generic anesthetics,...

Tryp Therapeutics, Inc.  ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the World Intellectual Property Organization...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused...

Veteran public health leader Anuradha Gupta, who has spearheaded a host of successful global initiatives to improve the health of women and children and boost vaccine access and uptake, has joined Sabin Vaccine Institute as President of Global...

This weekend, the team at Adventure Vision will be celebrating their grand opening in Commerce City with a day of free vision care for kids in need in partnership with Von's Vision, the charity founded by Denver Broncos football legend and current...

Biogen Inc. announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BIIB800, a biosimilar candidate referencing RoACTEMRA®1 (tocilizumab), an anti-interleukin-6 receptor monoclonal antibody....

September 30, 2022 Amsterdam, the Netherlands ? Royal Philips announced that today's Extraordinary General Meeting of Shareholders (EGM) appointed Roy Jakobs as the company's next President and Chief Executive Officer, effective October 15, 2022,...

Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present...

Theralase® Technologies Inc. ("Theralase" or "Company") , a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations intended to safely...

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that they opened an office in...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced that, following a Type A meeting with the U.S. Food and Drug Administration...

Grow Up Conference and Expo ("Grow Up") has completed its sixth annual event based in Niagara Falls, this year being held from Sunday, September 11th until Tuesday, September 13th. Grow Up provided a 2-day conference schedule, a collaborative B2B...

Silent, possibly deadly, ever increasing and unknowingly present in over 10 million Canadians, is the liver disease known as NAFLD, now a Canadian epidemic. NAFLD, (non-alcoholic fatty liver disease) is the accumulation of fat in the liver. Risk...

Rakovina Therapeutics Inc. ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce two upcoming conference presentations. The 34th...

Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar's...

Resverlogix Corp. ("Resverlogix" or the "Company") today announced that apabetalone's future clinical development related to COVID-19 will focus on the prevention and treatment of Post COVID-19 Conditions (PCC), colloquially known as long-COVID, as...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company's U.S. Food & Drug...

BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce filing of a PCT patent application along...

Entourage Health Corp.  ("Entourage" or the...

Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated...

The Canadian Centre on Substance Use and Addiction (CCSA) welcomes the planned federal cannabis review and looks forward to opportunities to contribute evidence on public health, public safety and equity. This evidence is based on research by our...

Tryp Therapeutics, Inc. ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced the filing of two new provisional patent applications....